Graphene family nanomaterials
(GFNs) are rapidly emerging for ocular
applications due to their outstanding physicochemical properties.
Since the eyes are very sensitive organs and the contact between the
eyes and GFNs in eye drops, contact lenses, intraocular drug delivery
systems and biosensors and even the workers handling these nanomaterials
is inevitable, it is necessary to investigate their ocular toxicities
and physiological interactions with cells as well as their toxicity
mechanisms. The toxicity of GFNs can be extremely affected by their
physicochemical properties, including composition, size, surface chemistry,
and oxidation level as well as dose and the time of exposure. Up to
now, there are several studies on the
in vitro
and
in vivo
toxicity of GFNs; however, a comprehensive review
on ocular toxicity and applications of GFNs is missing, and a knowledge
about the health risks of eye exposure to the GFNs is predominantly
unspecified. This review highlights the ocular applications of GFNs
and systematically covers the most recent advances of GFNs’
physicochemical properties,
in vitro
and
in vivo
ocular toxicity, and the possible toxicity mechanisms
as well as provides some perspectives on the potential risks of GFNs
in material development and biomedical applications.